Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II Proceeding/Conference:Journal of Clinical Oncology | 2012 |